4.30
Precedente Chiudi:
$4.34
Aprire:
$4.35
Volume 24 ore:
33,224
Relative Volume:
0.05
Capitalizzazione di mercato:
$239.36M
Reddito:
$163.78M
Utile/perdita netta:
$25.88M
Rapporto P/E:
6.6154
EPS:
0.65
Flusso di cassa netto:
$-28.66M
1 W Prestazione:
+5.29%
1M Prestazione:
+0.85%
6M Prestazione:
+30.50%
1 anno Prestazione:
-30.99%
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Nome
Voyager Therapeutics Inc
Settore
Industria
Telefono
857-259-5340
Indirizzo
75 HAYDEN AVENUE, LEXINGTON, MA
Confronta VYGR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
VYGR
Voyager Therapeutics Inc
|
4.305 | 241.86M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.55 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
729.33 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.22 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
905.88 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.10 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Iniziato | Citigroup | Buy |
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-10-16 | Iniziato | Leerink Partners | Outperform |
| 2024-03-26 | Iniziato | Guggenheim | Buy |
| 2024-03-19 | Iniziato | H.C. Wainwright | Buy |
| 2024-03-07 | Iniziato | Citigroup | Buy |
| 2024-01-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Iniziato | Truist | Buy |
| 2023-03-10 | Iniziato | Oppenheimer | Outperform |
| 2021-10-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-02-03 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-12-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Iniziato | Oppenheimer | Outperform |
| 2018-11-15 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-09-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-02-02 | Iniziato | Morgan Stanley | Overweight |
| 2017-11-28 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2017-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-23 | Reiterato | Stifel | Buy |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-28 | Ripresa | Stifel | Buy |
Mostra tutto
Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie
Is Voyager Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 EndofMonth & Weekly Momentum Stock Picks - Newser
Ready to Jump After Recent Trade: Voyager Therapeutics Inc (VYGR) - Setenews
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Voyager Therapeutics Inc. stock undervalued vs historical averagesMarket Sentiment Report & AI Enhanced Execution Alerts - BỘ NỘI VỤ
Is Voyager Therapeutics Inc a good long term investmentPortfolio Risk Assessment & Budget Friendly Trading Strategies - earlytimes.in
Voyager Therapeutics (NASDAQ:VYGR) Shares Pass Below Fifty Day Moving AverageHere's What Happened - MarketBeat
A History of Outperforming Analyst Forecasts and Beating the Odds: Voyager Therapeutics Inc (VYGR) - Setenews
J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline - Benzinga
We're A Little Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Rate - Yahoo Finance
Why Voyager Therapeutics Inc. stock is rated strong buyCEO Change & Smart Money Movement Alerts - newser.com
How Voyager Therapeutics Inc. stock performs in weak economyJuly 2025 Patterns & Reliable Volume Spike Alerts - newser.com
Will Voyager Therapeutics Inc. stock split again soonJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
How rising interest rates impact Voyager Therapeutics Inc. stock2025 Dividend Review & Short-Term High Return Ideas - newser.com
Developing predictive dashboards with Voyager Therapeutics Inc. dataBreakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Key resistance and support levels for Voyager Therapeutics Inc.2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Using R and stats models for Voyager Therapeutics Inc. forecastingWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
What high frequency data says about Voyager Therapeutics Inc.2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Can Voyager Therapeutics Inc. stock hit record highs again2025 Market Trends & Weekly Watchlist for Hot Stocks - newser.com
Sentiment analysis tools applied to Voyager Therapeutics Inc.Earnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
FY2025 Earnings Forecast for VYGR Issued By HC Wainwright - Defense World
What drives Voyager Therapeutics Inc stock priceHigh Dividend Yield Stocks & Outstanding Growth Strategies - earlytimes.in
Benign Growth For Voyager Therapeutics, Inc. (NASDAQ:VYGR) Underpins Stock's 26% Plummet - simplywall.st
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):